Market Flux Event
Sanofi Weighs Takeover of Insmed in Deal That Would Be One of Pharma's Largest in Years
Read this in the Market Flux appFrench pharmaceutical giant Sanofi is evaluating an acquisition of US biopharma company Insmed, Bloomberg News reported on November 19, citing people familiar with the matter who asked not to be identified. Paris-based Sanofi is speaking with advisers as it studies a potential deal for the respiratory diseases specialist, driven by its search for the next blockbuster treatment under a new chief executive.
Insmed carried a market value of roughly $26.28 billion at the time of the report. Shares of the Nasdaq-listed company surged as much as 18%, trading at approximately $141.84, up about $22, as investors priced in a takeover premium. The deal would rank among the largest biotech acquisitions in recent history, according to Investor's Business Daily.
Deliberations are described as ongoing and any transaction could still be weeks away, with no agreement reached. Neither Sanofi nor Insmed has publicly confirmed that negotiations are taking place. Insmed's portfolio focuses on treatments for serious respiratory and inflammatory diseases, assets that would expand Sanofi's presence beyond its existing franchises as the company hunts for growth under new leadership.
© AI-generated summary is provided by Market Flux
Sources
- FirstSquawkSANOFI IS SAID TO WEIGH TAKEOVER OF US DRUGMAKER INSMED
- Seeking AlphaInsmed jumps on report of Sanofi takeover interest
- InvestingWhy is Insmed stock surging today?
- BarronsInsmed Stock Already Was Flying High. Sanofi Takeover Buzz Lights the Afterburners.
- BarronsonlineInsmed stock jumps following a report saying Sanofi is eyeing a takeover of the biopharma company.
- BenzingaBiohaven Stock Climbs On Early Cancer Data
- BusinessThe biotech boom coming out of China suffered a setback after a US FDA cancer drug rejection. More data is on the horizon that could turn things around.
- ReutersSanofi weighs takeover of US drugmaker Insmed, Bloomberg News reports
Show 1 more
- Investors Business DailySanofi Reportedly Gears Up For The Biggest Biotech Deal In Years